352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Arcus Biosciences entered a Loan and Security Agreement with Hercules Capital on August 27, 2024, providing a secured term loan facility of up to $250.0 million. Only $50.0 million was funded at closing, with the rest available under later tranches at the company's option or the lenders' option, and the loans are secured by substantially all company assets.
$50.0 million funded on August 27, 2024; up to $150.0 million more available at the company's option through March 15, 2026, and a further $100.0 million at the lenders' option
Interest at the greater of Prime Rate plus 1.95% or 10.45%; interest-only payments until September 1, 2028; maturity September 1, 2029
Financial covenant requires Qualified Cash of at least 50% of outstanding principal when market capitalization is at or below $1.20 billion, with reductions upon milestones
Arcosa closed a $600 million offering of 6.875% senior notes due 2032 on August 26, 2024, issued at 100% of face value. The company plans to use the proceeds, with expected borrowings under a Term Loan B facility due 2031, to fund its previously announced acquisition of the construction materials business of Stavola Holding Corporation. If the Stavola acquisition does not close by December 1, 2024, the notes must be redeemed at 100% of principal plus accrued interest, so the deal's completion affects this debt.
$600 million aggregate principal of 6.875% senior notes due August 15, 2032, sold at 100% of face value
Proceeds, with Term Loan B borrowings, to fund the Stavola Holding construction materials acquisition
Special redemption at 100% of principal plus accrued interest if the acquisition is not completed by December 1, 2024
Interest payable each February 15 and August 15, beginning February 15, 2025
On August 22, 2024, Noble Finance II LLC, a wholly owned subsidiary of Noble Corporation plc, closed a private offering of $800 million of additional 8.000% Senior Notes due 2030, issued under the same indenture as $600 million of notes sold in 2023. A Second Supplemental Indenture signed the same day permits the issuer to pay a dividend to Noble to fund the cash consideration for Noble's pending merger with Diamond Offshore Drilling, Inc., which means the new debt sits at the subsidiary level and adds to the company's borrowing while the merger is pending.
$800 million of 8.000% Senior Notes due 2030 closed August 22, 2024, sold in a private offering to eligible purchasers
New notes are treated as a single series with the $600 million Existing Notes issued in 2023 under the April 18, 2023 indenture
Second Supplemental Indenture, dated August 22, 2024, allows a dividend from the issuer to Noble to fund cash consideration for the pending Diamond Offshore Drilling, Inc. merger
IDEX Corporation completed an underwritten public offering of $500.0 million in 4.950% Senior Notes due 2029, with net proceeds of approximately $495.0 million. The company plans to use the proceeds, along with revolving credit borrowings and cash on hand, to pay the cash consideration for its previously announced acquisition of Mott Corporation.
$500.0 million of 4.950% Senior Notes issued August 21, 2024, maturing September 1, 2029
Net proceeds of approximately $495.0 million after underwriting discount and about $1.7 million in offering expenses
If the Mott Acquisition does not close by the Special Mandatory Redemption End Date (no earlier than November 20, 2024), the notes must be redeemed at 101% of principal plus accrued interest
JetBlue issued $400 million of 2.50% Convertible Senior Notes due 2029 on August 16, 2024, in a private placement under Rule 144A. The company used the proceeds to repurchase part of its existing 0.50% convertible notes due 2026 and to pay offering fees and expenses. The filing shows new debt that carries a conversion price about 27.5% above the August 12, 2024 share price, and it does not report any change in operating results.
Notes: $400 million principal, 2.50% annual interest, paid semi-annually, maturing September 1, 2029
Initial conversion price of approximately $6.12 per share, a 27.5% premium over the $4.80 close on August 12, 2024
Proceeds used to repurchase part of the 0.50% convertible notes due 2026 and to pay offering fees and expenses
Company may not redeem the notes before September 1, 2027
Arcosa signed Amendment No. 1 to its credit agreement on August 15, 2024, to permit and help finance its $1.2 billion cash acquisition of Stavola's construction materials business. The amendment adds a $700.0 million Term Loan B, increases the revolving credit facility from $600.0 million to $700.0 million, and adds substantially all of the company's personal property as collateral; the Term Loan and collateral terms take effect only when conditions, including the closing of the acquisition, are met.
Credit agreement amendment dated August 15, 2024, with JPMorgan Chase Bank, N.A. as administrative agent
Term Loan of up to $700.0 million at SOFR plus 2.25%, due on the seventh anniversary of initial funding
Revolving credit facility increased from $600.0 million to $700.0 million; maximum leverage ratio set at 5.00 to 1.00 in the quarter the transaction closes
Acquisition is financed with the Term Loan plus $600.0 million of 6.875% senior unsecured notes due 2032
Quest Diagnostics issued $1.85 billion of senior notes in three tranches due 2027, 2029 and 2034, with the offering priced on August 15, 2024 and closing on August 19, 2024. The company said it intends to use the proceeds mainly to fund the purchase price of its previously announced LifeLabs acquisition, which adds debt tied to that deal.
$400 million of 4.600% senior notes due December 15, 2027, $600 million of 4.625% notes due 2029, and $850 million of 5.000% notes due 2034
If the LifeLabs acquisition is not completed by the Termination Date, the 2027 and 2029 notes must be redeemed at 101% of principal plus accrued interest; the 2034 notes remain outstanding
Interest is paid June 15 and December 15 each year, beginning December 15, 2024
UDR, Inc. entered into a second amendment to its credit agreement on August 14, 2024, extending its $1.3 billion senior unsecured revolving credit facility and adding an extension option to its $350 million term loan. The amended agreement allows total commitments and borrowings to be increased to up to $2.5 billion, subject to conditions, which gives the company expanded borrowing capacity.
Revolving Credit Facility matures August 31, 2028, with two six-month extension options
Term Loan matures January 31, 2027, with one twelve-month extension option
Accordion feature allows up to $2.5 billion in aggregate commitments and borrowings, subject to lender commitments
Based on current credit rating, revolver margin is 77.5 basis points and facility fee is 15 basis points
Cousins Properties' operating partnership issued $500 million of 5.875% senior notes maturing October 1, 2034, guaranteed by the company. Proceeds will mainly repay revolving loans under its credit facility, with any remainder used for general corporate purposes. The filing adds new long-term debt but does not report a change in operating results.
$500 million principal amount of 5.875% senior notes due October 1, 2034, issued August 16, 2024
Interest payable semi-annually on April 1 and October 1, starting April 1, 2025
Net proceeds to repay revolving credit facility loans, with remainder for working capital and other corporate purposes
Indenture requires total unencumbered assets of at least 150% of total unsecured debt
BorgWarner completed the issuance of $500 million of 4.950% Senior Notes due 2029 and $500 million of 5.400% Senior Notes due 2034, totaling $1 billion. The notes were issued under an indenture with Deutsche Bank Trust Company Americas as trustee for the notes, supplementing the company's 1999 base indenture. The filing is a debt financing that adds $1 billion to the company's borrowings, and it does not disclose use of proceeds or results.
$500 million of 4.950% Senior Notes due 2029 issued August 16, 2024
$500 million of 5.400% Senior Notes due 2034 issued August 16, 2024
Notes governed by Ninth Supplemental Indenture with Deutsche Bank Trust Company Americas as trustee
PulteGroup's subsidiary Pulte Mortgage LLC amended its Master Repurchase Agreement with JPMorgan Chase, which funds mortgage loan origination. The amendment extends the facility to August 13, 2025, or an earlier termination date, and sets a maximum aggregate commitment of $675 million that steps down to $650 million on January 14, 2025. The filing is a financing renewal and reduction in the commitment, not a new source of capital beyond the existing facility.
Agreement entered into August 14, 2024 with JPMorgan Chase as Agent and other Buyers
Maximum aggregate commitment of $675 million, with an accordion feature to $725 million if existing Buyers increase commitments
Commitment decreases to $650 million on January 14, 2025; facility extended to the earlier of August 13, 2025 or termination
Essential Utilities, Inc. issued $500 million of 4.800% senior notes maturing August 15, 2027, under an indenture with U.S. Bank Trust Company as trustee. The filing describes routine debt financing terms, including semi-annual interest payments and a make-whole redemption option before July 15, 2027.
Principal amount: $500 million, issued August 15, 2024
Interest rate of 4.800% per year, paid semi-annually on February 15 and August 15, starting February 15, 2025
Maturity date August 15, 2027; redeemable before July 15, 2027 at the greater of a make-whole amount or par
Holders of at least 25% of outstanding notes may accelerate payment upon certain events of default
DaVita completed a $1.0 billion private offering of 6.875% senior notes due 2032 on August 13, 2024, and entered into a credit agreement amendment adding a $1.1 billion incremental term loan maturing April 28, 2028. The company said net proceeds of about $2,080.7 million were used to repay roughly $950.0 million of Tranche B-1 term loans and $60.0 million of revolving loans, with $350.0 million more of revolving loans planned for repayment. The refinancing changes the company's debt mix and interest costs, but the filing does not state the effect on total debt.
$1.0 billion of 6.875% senior notes due September 1, 2032, issued in a private offering completed August 13, 2024
$1.1 billion incremental Term Loan A-1 facility maturing April 28, 2028, with quarterly amortization starting September 30, 2024
Net proceeds of about $2,080.7 million used to repay roughly $950.0 million of 2026 term loans and $60.0 million of revolving loans
Remaining proceeds planned for $350.0 million of revolving loan repayment and general corporate purposes, including possible share repurchases
WisdomTree issued $345.0 million of 3.25% convertible senior notes due 2029 on August 13, 2024, which netted approximately $337 million in proceeds. On the same day, the company closed its repurchase of all 14,750 outstanding Series A Preferred shares from ETFS Capital Limited, which were convertible into 14,750,000 common shares. Shareholders could face dilution if the notes convert, as up to 35,751,281 common shares may be issued at the maximum conversion rate.
Notes: $345.0 million principal, 3.25% annual interest, maturing August 15, 2029; initial conversion price of approximately $11.82 per share
Net proceeds of approximately $337 million; the Initial Purchaser also exercised its option to buy $45.0 million of additional notes
Series A Preferred Stock: all 14,750 shares repurchased and retired, with the transaction closing August 13, 2024
Up to 35,751,281 common shares may be issued on conversion, based on the maximum conversion rate of 103.6269 shares per $1,000 principal
Elanco Animal Health entered an incremental assumption agreement under its existing senior secured credit facility, adding a new $350 million term loan. Proceeds will repay outstanding obligations under an existing term loan and fund general corporate purposes. The filing says the new facility's interest rate and repayment terms are generally consistent with the existing term loan.
New incremental term facility totals $350,000,000 under the Credit Agreement dated August 1, 2020
Proceeds will repay outstanding obligations under an existing term loan and for general corporate purposes
Facility matures on August 13, 2031; terms generally consistent with the existing term loan
Lenders include Farm Credit Mid-America, PCA as incremental term lender and Goldman Sachs Bank USA as term facility agent
KeyCorp entered an Investment Agreement with The Bank of Nova Scotia to sell common shares in two closings at a fixed price of $17.17 per share, for approximately $2.8 billion in aggregate consideration. After the second closing, the Bank of Nova Scotia would hold about 14.9% of KeyCorp's outstanding common shares and would be entitled to designate two board representatives.
Fixed price of $17.17 per share; aggregate consideration of approximately $2.8 billion
First closing gives the purchaser 4.90% of outstanding shares; second closing, subject to bank regulatory approvals, brings it to 14.90%
Two board designees upon the second closing; standstill limits the purchaser to 19.99% ownership
Purchaser's shares are locked up for one year after the second closing; shares issued under Section 4(a)(2) exemption
On August 12, 2024, DoubleVerify Inc. entered a credit agreement for a new $200.0 million senior secured revolving credit facility that replaces its existing revolver in full. The facility matures August 12, 2029, and the filing says it is guaranteed by DoubleVerify Holdings, Inc. and secured by assets of certain subsidiaries, but not by the parent company itself. The agreement includes covenants that restrict dividends, share repurchases, additional debt and acquisitions, and requires a maximum total net leverage ratio of 4.50:1.00.
$200.0 million senior secured revolving facility, with a letter of credit sublimit of up to $20.0 million, terminating August 12, 2029.
Replaces the existing revolving facility under a credit agreement dated October 1, 2020.
Interest at Term SOFR plus 2.00% to 2.75%, or ABR plus 1.00% to 1.75%, depending on total net leverage; commitment fee of 0.25% to 0.35%.
Maximum total net leverage ratio of 4.50:1.00 tested each quarter beginning with the quarter ending March 31, 2025; covenants limit dividends and share repurchases.
RXO agreed to sell 20,954,780 common shares at $20.21 per share, plus pre-funded warrants for 6,259,471 shares, to MFN Partners and Orbis Investments in a private placement with gross proceeds of about $550.0 million. The company plans to use the net proceeds to partially fund its pending acquisition of Coyote Logistics, and the placement is expected to close on August 13, 2024. Shareholders would see more shares outstanding once the placement closes and the warrants are exercised.
Common stock sold at $20.21 per share, the June 21, 2024 closing price before the Coyote Logistics agreement was announced.
Pre-funded warrants for 6,259,471 shares priced at $20.20 each, with $0.01 exercise price.
Investors agreed to a 120-day lock-up; RXO must file a resale registration statement within 90 days after closing.
Stockholder approval for part of the warrant shares must be sought no later than December 31, 2024.
Host Hotels & Resorts' operating partnership completed a $700 million public offering of 5.500% Series L senior notes due 2035 on August 12, 2024. The company plans to use the proceeds to repay all $525 million of revolver borrowings, including amounts used for recent hotel acquisitions, which keeps the credit facility's commitments intact.
Host L.P. sold $700 million of 5.500% Series L senior notes due 2035, completed August 12, 2024
Net proceeds intended to repay all $525 million outstanding under the revolver, without reducing commitments
Borrowings partly tied to recent acquisitions of The Ritz-Carlton O'ahu, Turtle Bay and 1 Hotel Central Park
Notes can be redeemed before January 15, 2035 at the greater of par or a make-whole price set at Treasury plus 30 basis points
FirstCash Holdings amended its unsecured revolving credit facility on August 8, 2024, increasing the lender commitment from $640 million to $700 million and extending the maturity from August 2027 to August 2029. The amendment also raises the permitted consolidated leverage ratio to 3.25 times adjusted EBITDA for the full term, while other financial covenants remain substantially unchanged. The company said the added capacity supports growth in the U.S. and Latin America and future shareholder payouts through cash dividends and share repurchases.
Lender commitment increased from $640 million to $700 million
Maturity extended from August 30, 2027 to August 8, 2029
Permitted consolidated leverage ratio raised to 3.25 times adjusted EBITDA for the full term
Interest at SOFR plus a fixed 2.5% spread, or prime or base rate plus a fixed 1.5% spread, at the borrower's option
National Vision agreed to repurchase about $218 million of its 2.50% convertible notes due 2025 for about $215 million in cash plus accrued interest. The company will fund the purchase with $115 million of new incremental term loans and cash on hand, with the repurchase expected to close on or about August 12, 2024. About $85 million of the 2025 notes will remain outstanding after closing, and the new loans add to the company's term debt.
Repurchase of about $218 million principal of 2.50% Convertible Senior Notes due 2025 for about $215 million cash, plus accrued interest
$115 million of incremental term loans, provided August 9, 2024, on the same terms as existing term loans
Repurchase expected to close on or about August 12, 2024; about $85 million of 2025 notes will remain outstanding
Joinder Agreement signed August 9, 2024, with Bank of America, N.A. as administrative agent
RXO entered Amendment No. 4 to its revolving credit agreement on August 8, 2024, with Goldman Sachs Bank USA as administrative agent. The amendment extends the maturity of the $600 million revolving facility, adds a $200 million delayed draw term loan that may fund the Coyote Acquisition from UPS subsidiaries, and caps the consolidated leverage ratio at 4.50 to 1.00. The filing says the existing lenders also consented to the Coyote Acquisition under Amendment No. 3.
Revolving credit facility of $600 million; maturity extends five years once the term loan is funded or the Coyote conditions are met or waived.
$200 million delayed draw term loan may be used to fund the Coyote Acquisition under a Purchase Agreement dated June 21, 2024 with UPS subsidiaries.
Consolidated leverage ratio may not exceed 4.50 to 1.00; term loan amortization begins with the fiscal quarter ending December 31, 2026.
Lenders consented to the Coyote Acquisition in Amendment No. 3, dated July 31, 2024.
WisdomTree announced a private offering of $300 million of convertible senior notes due 2029, subject to market conditions. Proceeds are intended in part to repurchase about $104 million of its 5.75% convertible notes due 2028 and to help fund a roughly $144 million cash repurchase of its Series A Preferred Stock from ETFS Capital Limited. The preferred repurchase depends on the offering closing and the 2028 note repurchases, so the outcome and final terms are not yet set.
Offering of $300 million convertible senior notes due 2029 to qualified institutional buyers, with an option for up to $45 million more; interest rate and conversion terms to be set at pricing
About $104 million of 5.75% convertible senior notes due 2028 targeted for repurchase; amounts depend on negotiations with holders
All 14,750 Series A Preferred shares, convertible into 14.75 million common shares, to be repurchased for approximately $144 million in cash, with the price based on the average stock price over four trading days
Related Investor Rights Agreement with ETFS Capital Limited to terminate at the repurchase closing
BorgWarner agreed on August 7, 2024 to sell $500 million of 4.950% senior notes due 2029 and $500 million of 5.400% senior notes due 2034, for $1 billion in total principal. The company said it will use the proceeds to repurchase any and all of its 3.375% notes due March 15, 2025 and 5.000% notes due October 1, 2025 that are validly tendered in tender offers, with any remainder for general corporate purposes. The filing is a debt refinancing and does not report new financial results.
Two tranches: $500 million of 4.950% notes due August 15, 2029 and $500 million of 5.400% notes due August 15, 2034
Interest payable semi-annually on February 15 and August 15, beginning February 15, 2025
Proceeds to repurchase 3.375% notes due March 15, 2025 and 5.000% notes due October 1, 2025 via tender offers, plus tender fees and expenses
Notes are general unsecured obligations; the indenture is with The Bank of New York Mellon Trust Company, N.A.
Permian Resources Operating, LLC, a subsidiary of Permian Resources Corporation, issued $1.0 billion of 6.25% senior unsecured notes due February 1, 2033 on August 5, 2024. Concurrently, the company ran a tender offer for its 7.75% senior notes due 2026, and holders tendered $298,703,000 of them, with the remaining outstanding 2026 notes set for redemption on February 15, 2025. The new notes add $1.0 billion of direct debt for shareholders, and the indenture contains covenants that limit dividends, asset sales and additional borrowing.
$1.0 billion of 6.25% senior notes issued August 5, 2024, maturing February 1, 2033, with the first interest payment due February 1, 2025
$298,703,000 (about 99.57%) of the 7.75% 2026 notes validly tendered at expiration, plus $850,000 more through guaranteed delivery by August 6, 2024
Remaining 2026 notes to be redeemed February 15, 2025; $481,642.50 deposited in trust to satisfy and discharge the 2026 indenture
Notes are guaranteed on a senior unsecured basis by Permian Resources Corporation (NYSE: PR)
Tennant Company entered a Second Amended and Restated Credit Agreement with JPMorgan Chase Bank as administrative agent, providing a senior secured revolving facility of up to $650 million through August 7, 2029. The facility can be expanded by up to $325 million and is secured by substantially all of the company's personal property and pledged subsidiary stock, which adds lender-related obligations and covenants that shareholders should note.
Revolving facility up to $650 million, maturing August 7, 2029, with an option to expand by up to $325 million
Borrowings in U.S. dollars priced off prime rate, NYFRB Rate or Adjusted Term SOFR, with spreads depending on leverage ratio
Covenants include a maximum indebtedness to EBITDA ratio of 3.75 to 1.00 and a minimum EBITDA to interest expense ratio of 3.00 to 1
Dividends and stock repurchases are limited when leverage exceeds 2.50 to 1, capped at the greater of 10% of consolidated total assets and $100 million per fiscal year
On August 2, 2024, Abercrombie & Fitch entered into a Second Amendment to its asset-based revolving credit agreement, increasing total commitments from $400 million to $500 million and extending maturity to August 2, 2029. The amendment also adds a $100 million sub-facility for its Netherlands and UK subsidiaries, and raises the interest rate margin on borrowings.
Aggregate commitments increase from $400 million to $500 million under the ABL facility
New $100 million sub-facility for Abfico Netherlands Distribution B.V. and AFH Stores UK Limited, secured by their assets
Maturity extended from April 29, 2026 to August 2, 2029
Interest rate margin rises to 1.50% or 1.75%, depending on average availability
On August 2, 2024, Veeco entered a Third Amendment to its Loan and Security Agreement with HSBC Bank USA as administrative agent. The amendment increases the senior secured revolving credit facility by $75 million to $225 million and adds Citizens Bank, N.A. as a lender. The filing does not state the reason for the increase or any draw on the facility.
Revolving credit facility increased by $75 million, from an unstated prior amount to $225 million aggregate principal
Citizens Bank, N.A. joined the Loan and Security Agreement as a lender
Agreement is dated as of December 16, 2021, and was previously amended in May 2023 and March 2024
On July 31, 2024, Sylvamo refinanced part of its long-term debt, extending several credit facilities and redeeming all $90.1 million of its 7% 2029 Notes. The revolving credit facility was cut from $450 million to $400 million, and the filing says the company reduced borrowing capacity because it no longer needed excess capacity. The filing reports no earnings or operating results, and says other terms are generally consistent with the prior agreements.
Revolving credit facility maturity extended from 2026 to July 31, 2029; capacity reduced from $450 million to $400 million.
New $235 million Term Loan F-2 Facility due July 31, 2031; $140 million borrowed at closing and $95 million available as a delayed draw for 60 days.
All outstanding $90.1 million of 7% 2029 Notes called for full redemption, funded by the new term loan.
Accounts receivable finance facility maturity extended from September 30, 2025 to July 30, 2027; size reduced from $120 million to $110 million.
Eastman Chemical Company issued $500 million of 5.000% notes maturing August 1, 2029, in a public offering that closed on August 1, 2024. The company expects net proceeds of about $494.4 million and plans to use part of them for a concurrent tender offer for up to $250 million of its 3.800% notes due 2025, with any remainder for general corporate purposes.
$500 million aggregate principal of 5.000% notes due August 1, 2029, issued August 1, 2024
Expected net proceeds of approximately $494.4 million after underwriting discounts and estimated expenses
Concurrent tender offer for up to $250 million of 3.800% notes due 2025; interest on new notes paid February 1 and August 1, starting February 1, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.